Avorn J - Search Results

1

Comparative effectiveness and safety of single inhaler triple therapies for chronic obstructive pulmonary disease: new user cohort study.

Feldman WB, Suissa S, Kesselheim AS, Avorn J, Russo M, Schneeweiss S, Wang SV. Feldman WB, et al. Among authors: avorn j. BMJ. 2024 Dec 30;387:e080409. doi: 10.1136/bmj-2024-080409. BMJ. 2024. PMID: 39797646

2

Academic Detailing Interventions and Evidence-Based Prescribing: A Systematic Review.

Rome BN, Dancel E, Chaitoff A, Trombetta D, Roy S, Fanikos P, Germain J, Avorn J. Rome BN, et al. Among authors: avorn j. JAMA Netw Open. 2025 Jan 2;8(1):e2453684. doi: 10.1001/jamanetworkopen.2024.53684. JAMA Netw Open. 2025. PMID: 39775805 Free article.

3

Government Funding for the Development of Enzalutamide.

Gyawali B, Jung EH, Mooney H, Avorn J, Kesselheim AS. Gyawali B, et al. Among authors: avorn j. JAMA Oncol. 2024 Dec 19. doi: 10.1001/jamaoncol.2024.5661. Online ahead of print. JAMA Oncol. 2024. PMID: 39699929

4

Interventional Pharmacoepidemiology: Origins, Current Status, and Future Possibilities.

Avorn J. Avorn J. Am J Epidemiol. 2024 Oct 10:kwae383. doi: 10.1093/aje/kwae383. Online ahead of print. Am J Epidemiol. 2024. PMID: 39390636

5

Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional study.

Tibau A, Hwang TJ, Avorn J, Kesselheim AS. Tibau A, et al. Among authors: avorn j. BMJ. 2024 Aug 20;386:e079126. doi: 10.1136/bmj-2023-079126. BMJ. 2024. PMID: 39164034 Free PMC article.

6

Clinical Value of Molecular Targets and FDA-Approved Genome-Targeted Cancer Therapies.

Tibau A, Hwang TJ, Molto C, Avorn J, Kesselheim AS. Tibau A, et al. Among authors: avorn j. JAMA Oncol. 2024 May 1;10(5):634-641. doi: 10.1001/jamaoncol.2024.0194. JAMA Oncol. 2024. PMID: 38573645

7

Pragmatic trial evaluating the impact of simulation training on high-risk prescribing to older adults by junior physicians.

Lauffenburger JC, DiFrancesco MF, Bhatkhande G, Crum KL, Kim E, Robertson T, Oran R, Hanken KE, Haff N, Coll MD, Avorn J, Choudhry NK. Lauffenburger JC, et al. Among authors: avorn j. J Am Geriatr Soc. 2024 May;72(5):1420-1430. doi: 10.1111/jgs.18862. Epub 2024 Mar 8. J Am Geriatr Soc. 2024. PMID: 38456561 Clinical Trial.

8

Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation.

Lin KJ, Singer DE, Avorn J, Heist EK, Sreedhara SK, Anand P, Zhang Y, Tsacogianis TN, Schneeweiss S. Lin KJ, et al. Among authors: avorn j. Circ Cardiovasc Qual Outcomes. 2024 Mar;17(3):e010279. doi: 10.1161/CIRCOUTCOMES.123.010279. Epub 2024 Mar 5. Circ Cardiovasc Qual Outcomes. 2024. PMID: 38440888

9

Use of Efficiency Frontiers to Align Prices and Clinical Benefits of Biologic Therapies for Plaque Psoriasis.

Egilman AC, Kesselheim AS, Avorn J, Raymakers AJN, Rome BN. Egilman AC, et al. Among authors: avorn j. JAMA Dermatol. 2024 Apr 1;160(4):409-416. doi: 10.1001/jamadermatol.2023.6236. JAMA Dermatol. 2024. PMID: 38381418

10

Characteristics of Patients Receiving Novel Muscular Dystrophy Drugs in Trials vs Routine Care.

Hong D, Avorn J, Wyss R, Kesselheim AS. Hong D, et al. Among authors: avorn j. JAMA Netw Open. 2024 Jan 2;7(1):e2353094. doi: 10.1001/jamanetworkopen.2023.53094. JAMA Netw Open. 2024. PMID: 38265797 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

616 results

Search Page

Filters